Company Quick10K Filing
Applied DNA Sciences
10-Q 2021-03-31 Filed 2021-05-13
10-Q 2020-12-31 Filed 2021-02-11
10-K 2020-09-30 Filed 2020-12-17
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-14
10-Q 2019-12-31 Filed 2020-02-06
10-K 2019-09-30 Filed 2019-12-12
S-1 2019-09-18 Public Filing
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-09
10-Q 2018-12-31 Filed 2019-02-07
10-K 2018-09-30 Filed 2018-12-18
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-05-03
10-Q 2017-12-31 Filed 2018-02-08
10-K 2017-09-30 Filed 2017-12-28
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-Q 2016-12-31 Filed 2017-02-09
10-K 2016-09-30 Filed 2016-12-06
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-12
10-Q 2015-12-31 Filed 2016-02-10
10-K 2015-09-30 Filed 2015-12-14
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-Q 2014-12-31 Filed 2015-02-09
10-K 2014-09-30 Filed 2014-12-15
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-12
10-Q 2013-12-31 Filed 2014-02-10
10-K 2013-09-30 Filed 2013-12-20
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-15
10-Q 2012-12-31 Filed 2013-02-14
10-K 2012-09-30 Filed 2012-12-20
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-12-31 Filed 2012-02-14
10-K 2011-09-30 Filed 2011-12-09
10-Q 2011-06-30 Filed 2011-08-10
10-Q 2011-03-31 Filed 2011-05-16
10-Q 2010-12-31 Filed 2011-02-14
10-K 2010-09-30 Filed 2010-12-15
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-10
10-Q 2009-12-31 Filed 2010-02-11
8-K 2021-02-11 Earnings, Exhibits
8-K 2021-01-19 Officers, Exhibits
8-K 2021-01-13 Regulation FD, Other Events, Exhibits
8-K 2021-01-10 Enter Agreement, Regulation FD, Exhibits
8-K 2020-12-17 Earnings, Exhibits
8-K 2020-10-19
8-K 2020-10-07
8-K 2020-10-02
8-K 2020-09-29
8-K 2020-09-16
8-K 2020-09-15
8-K 2020-08-06
8-K 2020-07-28
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-05-05
8-K 2020-02-06
8-K 2019-12-12
8-K 2019-12-04
8-K 2019-11-21
8-K 2019-11-15
8-K 2019-11-13
8-K 2019-11-07
8-K 2019-10-31
8-K 2019-10-01
8-K 2019-08-22
8-K 2019-08-13
8-K 2019-08-06
8-K 2019-07-30
8-K 2019-07-16
8-K 2019-05-16
8-K 2019-05-09
8-K 2019-03-28
8-K 2019-02-07
8-K 2019-01-29
8-K 2019-01-25
8-K 2018-12-26
8-K 2018-12-21
8-K 2018-12-13
8-K 2018-12-06
8-K 2018-11-29
8-K 2018-09-20
8-K 2018-08-31
8-K 2018-08-13
8-K 2018-05-03
8-K 2018-03-31
8-K 2018-02-27
8-K 2018-02-08

Applied DNA Sciences Financials

APDN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
30DC (TDCH)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
3D Total Solutions (DTLS)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash122,7471,9368571,2567259844,4061,8326,3604,1991,9882,0261,3932,87298410,7307,31212,3839,7867,0874,4796,7024,0202,4032,9604,7653,7092,5151,6603,1381,541507559
Accounts Receivable1782092333244432973624085886737496065188351,1151,1602,0783,9303,9245,0274,7926,3756,1565,1924,7462,5882,1561,5261,4151,486615316244840
Inventory127298323354377326314294295221225315310143
PP&E089821213664634634931,0021,1061,2081,2231,3151,3355215885271,4255628798062,0567246725902,1905005515362,4563693162652,519
Assets8943,5042,5221,4521,9701,3491,6255,0733,8418,3756,2413,7823,7713,5065,0223,62714,12315,55420,48517,71215,21915,56616,77013,21710,4238,1549,6097,9346,6085,6346,1494,2262,9853,565
Accounts Payable2144736036851,2496417709869051,0608869987701,2381,5991,9091,4791,5301,6581,1581,0163836024393875019446428391,152
Long-Term Debt2500320
Liabilities4,4993,8766386545928,3238,8441,5333,7594,3584,1033,4604,9751,7211,6711,6232,9872,4892,6843,0335,2004,5883,9262,4051,2961,4702,2263,5504,8795,3834,9604,7744,413
Stockholders' Equity-995-1,3548141,316757-6,698-3,7712,3084,6161,882-320311-1,4683,3011,95512,50012,56717,99615,02812,18610,36512,1829,2918,0186,8588,1385,7073,058755766-734-1,789-841
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2302815175185292913183456457295976378416461,2421,5192,2683,9801,3245736531,6369039051,7978476481,0441,0161,1958847782,0531,673
Cost of Revenue121442275297232273331372253251153133271320
Gross Profit5321,1946286081,5655743166727649457316451,7831,353
R&D4810778961001581481761851834593602662152783733106744727291,078832519636603525740670625717710651720887
SG&A1,5813,8602,1521,8251,7531,8862,5212,7543,2412,6823,8463,2982,9483,1564,6712,9013,5083,6583,5543,1202,7072,6233,9013,2303,4032,7902,5931,9972,8823,5723,0822,5292,4072,260
Tax00000000000000000000000000000000015
Net Income-2,155-2,410-1,544-1,430-1,767-8,705-3,128-2,136-3,718-6,292-2,750-1,919-2,106-7,829-1,886-1,671-496-2,926-3,468-3,367-2,415-3,961-3,429-2,611-2,855-3,184-2,146-2,888-3,475-3,234-2,687-1,478-1,224
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-812-1,032-1,124-993-1,740-2,149-1,808-2,173-2,066-2,196-2,008-2,242-2,356-1,616-1,255-1,739-2,721-2,503-2,227-2,446-2,069-2,630-1,866-914-2,573-707-2,509-1,514-2,288-1,283-1,777
Cash Investing0-47-19-970-30-768-423-95-15-100-20-31-202-227-1,679-66-94-472-147-43-51-18-34-48-1554-52-12-41
Cash Financing5582,0005,60027,12501,6293,865-7011,22807,85800-144,33402661,5054,426-1931,6503,0447042541,827